Skip to Main Content

The (POGO) Blog

July 13, 2016

By David S. Hilzenrath

Faulty Blood Testing Devices to Be Withdrawn from Market



Photograph of a finger prick with blood drop Alere, maker of INRatio blood testing devices whose potentially fatal flaws POGO spotlighted, said it is taking the machines off the market.

Continue Reading Faulty Blood Testing Devices to Be Withdrawn from Market

Topics: Government Accountability, Public Health and Science

April 22, 2016

By Danielle Brian

POGO Wins National Journalism Prize for Reporting on FDA



Emergency Room Gurney 120 The Society of Professional Journalists has awarded the Project On Government Oversight a Sigma Delta Chi Award for POGO’s coverage of potentially deadly weaknesses in FDA oversight of prescription drugs.

Continue Reading POGO Wins National Journalism Prize for Reporting on FDA

Topics: Government Accountability, Public Health and Science

March 24, 2016

By David S. Hilzenrath

FDA to Tighten Standards for Blood-Test Devices



Venipuncture Tackling a problem POGO spotlighted, the FDA plans to tighten standards for error-prone blood-testing devices linked to deaths and injuries in patients taking the blood thinner warfarin.

Continue Reading FDA to Tighten Standards for Blood-Test Devices

Topics: Government Accountability, Public Health and Science

March 15, 2016

By David S. Hilzenrath

Drug Problems: Did Bad Blood Tests Turn a Clinical Trial into a Mistrial?



Photograph of Prescription Drugs on Twenty Dollar Bills Recent studies by the European Medicines Agency and a team based at Duke University dismissed concerns that malfunctioning testing devices compromised a clinical trial of the blood thinner Xarelto, but each of those studies leaves questions.

Continue Reading Drug Problems: Did Bad Blood Tests Turn a Clinical Trial into a Mistrial?

Topics: Public Health and Science

February 4, 2016

By David S. Hilzenrath

FDA Nominee Califf Gave Questionable Answers to Senate



Robert Califf FDA Nomination Hearing Robert Califf, a former Duke University researcher who is awaiting Senate confirmation as FDA commissioner, gave questionable answers to the Senate about the independence of clinical trials conducted for drug companies.

Continue Reading FDA Nominee Califf Gave Questionable Answers to Senate

Topics: Public Health and Science

Items 6 - 10 of 18  Previous1234Next

Browse POGOBlog by Topic

POGO on Facebook